Pertrin (Permethrin)

Quick links to important sections

Pertrin (Permethrin)

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pertrin (Permethrin)

The medicine Pertrin contains the active ingredient Permethrin, which is a highly effective, synthetic agent used exclusively for the topical elimination of parasitic infestations. This drug is classified as a scabicide and pediculicide, recognizing its specific purpose in treating the conditions caused by mites and lice.

Property Description
Active ingredient Permethrin
Form Cream, Lotion, Shampoo
Pharmacological class Scabicide, Pediculicide
Common use Elimination of mites (scabies) and lice (pediculosis)
Origin Synthetic pyrethroid, structurally similar to natural pyrethrins

Classification and Differentiating Features of Permethrin

Permethrin is a single-ingredient medication and a synthetic pyrethroid, a compound structurally related to natural extracts found in the chrysanthemum flower. Permethrin is clinically recognized for its neurotoxic action against arthropods, making it a targeted treatment against mites and lice. This means the medicine works by chemically disrupting the pests’ nervous system, which leads to their rapid paralysis and death.

A key differentiating feature of Permethrin is its dual availability; the lower-concentration lotion or shampoo (typically 1%) is often available over-the-counter for treating head lice, while the higher-concentration cream (typically 5%) is generally prescription-only and indicated for the treatment of scabies. This tiered regulatory approach based on concentration and target infestation is unique to the substance's identity.


General Purpose and Forms for Topical Application

The overall purpose of using Pertrin (Permethrin) is the interruption and elimination of parasitic infestations in humans, such as the mites that cause scabies, or lice (head and pubic). The use of permethrin is established as a first-line treatment option for both scabies and pediculosis capitis.

As a topical treatment, Permethrin is formulated into various preparations—including a cream, a lotion, and a shampoo—to ensure optimal delivery to the affected site. This range of forms ensures the active ingredient can be efficiently applied and maintained in contact with the parasitic location. For example, the cream base allows for comprehensive skin coverage necessary for treating scabies, while the lotion is specifically designed to saturate the hair and scalp for a head lice treatment scenario.

Regulatory References

  1. Permethrin - StatPearls (NCBI Bookshelf)

What side effects are possible with Pertrin (Permethrin)?

Possible Side Effects and Safety Information

The safety profile of topical Permethrin is defined by its low systemic absorption, with most adverse reactions being localized and related to the site of application. Regulatory documents classify side effects based on frequency and affected body systems.


Adverse Reaction Scope

Classification System-Organ Class Examples Listed in Regulatory Documents
Common / Very Common Skin and Subcutaneous Tissue Disorders Burning sensation, stinging, transient redness (erythema), and a worsening of pre-existing itching (pruritus).
Uncommon / Rare Nervous System Disorders Paresthesia (tingling/prickling).
Uncommon / Rare Immune System Disorders Allergic reactions, including urticaria and contact dermatitis.

Serious Adverse Reactions and Key Restrictions

The most clinically significant risk documented in official labeling is the potential for Severe Hypersensitivity Reactions or systemic allergic response, although these are rare. The product is strictly for external use only.

Use is formally contraindicated in individuals with a known allergy or hypersensitivity to permethrin, other synthetic pyrethrins, or any component of the specific formulation. If contact with eyes occurs, regulatory notes advise immediate flushing with water.

Population-Specific Safety Considerations

The official prescribing information includes specific limitations regarding age. The safety and effectiveness of the higher-concentration formulations (e.g., 5% cream) have not been established for use in infants younger than two months of age.

Time-Related Safety Patterns

Common effects like burning and stinging are generally considered mild and transient, often appearing shortly after application. It is officially noted that the worsening of pruritus can persist for up to four weeks after successful treatment, which is typically considered part of the healing process rather than treatment failure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Pertrin (Permethrin) overdose centers on scenarios of accidental ingestion of the topical product, as systemic absorption from proper use is low. Overdose manifestations documented in prescribing information primarily include gastrointestinal and neurological effects. Treatment is officially described as symptomatic and supportive.

Documented Overdose Manifestations

Exposure Pathway Documented Symptoms Severe Outcomes
Accidental Ingestion Nausea, Vomiting, Headache, Dizziness Convulsion, Seizures
Excessive Topical Use Localised adverse reactions, more severe skin reactions Not associated with systemic toxicity

Required Emergency Actions

Regulatory authorities mandate specific actions for accidental exposure. If accidental ingestion of Pertrin (Permethrin) is suspected, seek immediate medical advice and call a Poison Control Center. Urgent medical help, including calling emergency services (911), is required immediately if the affected person shows signs of severe systemic distress, such as being collapsed or not breathing. No specific antidote is known for Permethrin overdose. For accidental ingestion by a child, gastric lavage should be considered as a procedural step if performed within two hours, as specified in regulatory documents.

Therapeutic Uses of Pertrin (Permethrin)

What Pertrin (Permethrin) Treats: Main Uses and Benefits

Pertrin, which contains the active ingredient permethrin, is a topical medication used primarily to treat parasitic infestations of the skin and hair. As a synthetic pyrethroid, it works by disrupting the nervous systems of specific insects and mites, leading to their elimination.

Main Therapeutic Uses

Scabies Treatment

One of the primary applications of permethrin is the treatment of scabies. This condition is caused by microscopic mites that burrow into the upper layer of the skin to live and lay eggs. The medication is used to eradicate both the mites and their eggs, helping to resolve the intense itching and skin rash associated with the infestation.

Head Lice Eradication

Pertrin is also used to treat pediculosis, commonly known as head lice. This condition involves small insects that attach themselves to the hair on the scalp. The treatment targets the active lice and, in many cases, helps manage the presence of nits (lice eggs), thereby breaking the life cycle of the parasite.

Pubic Lice (Crabs)

In addition to head lice, permethrin is effective against pubic lice. Similar to other infestations, the medication works by targeting the parasites residing in the affected body hair areas.

Benefits of Treatment

  • Targeted Action: The medication is designed to act specifically on the nervous system of parasites while remaining suitable for topical application on human skin.
  • Symptom Relief: By eliminating the underlying cause of the infestation, the treatment helps alleviate secondary symptoms such as persistent itching, redness, and skin irritation.
  • Prevention of Spread: Effectively treating an infestation reduces the likelihood of transferring the parasites to other individuals through direct contact or shared personal items.
  • Efficiency: Permethrin is known for its high success rate in eliminating parasites, often requiring a limited number of applications to achieve complete clearance.

Regulatory References

  1. NIH MedlinePlus overview on Permethrin

Eligibility and Restrictions for Use

Who can and cannot use Pertrin (Permethrin)?

The eligibility for using Permethrin is strictly defined by regulatory documents based primarily on hypersensitivity status and age.

Eligibility Status Defined Regulatory Criteria
Absolute Contraindication Patients with a known hypersensitivity to Permethrin, other synthetic pyrethroids, or pyrethrins, or to any excipient in the specific formulation.
Established Use Adults and older adults with no contraindications, and pediatric patients aged 2 months and older (for 5% cream/scabicide formulations).
Use Not Established Infants less than 2 months of age. Safety and effectiveness have not been established in this age group, and its use is typically not recommended.

Age-Specific and Conditional Eligibility:

The 5% cream is established as safe and effective for children aged two months and older. No specific dosage adjustment or restriction is required for older adults or patients with impaired renal or hepatic function, as minimal systemic absorption occurs. Regarding pregnancy, the drug is classified as FDA Pregnancy Category B and should be used only if clearly needed. For nursing mothers, it is not known whether the drug is excreted in human milk; regulators advise considering discontinuing nursing temporarily.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Topical Permethrin is a medication with minimal systemic absorption, typically documented as less than two percent of the applied dose. Due to this low absorption and rapid metabolism, regulatory documents confirm the absence of documented systemic pharmacokinetic interactions with other medicinal products. This means that interactions involving drug-metabolizing enzymes, such as the Cytochrome P450 (CYP) system, or drug transporters, are not considered clinically relevant and are not listed in official prescribing information.


Documented Interaction Contexts

Interaction Type Official Regulatory Finding
Systemic Drug Interactions None documented. Risk is negligible due to minimal systemic absorption.
Food, Alcohol, Herbal Products Interactions with food, alcohol, or herbal supplements have not been established.
Local Treatments Concomitant use with local corticosteroids to treat eczema-like reactions may be restricted, as this combination carries a risk of exacerbating the parasitic infestation by reducing the local immune response.
Product Restriction The cream's excipients (such as white soft paraffin) may reduce the functioning and reliability of products made of latex, including condoms and diaphragms.

Interaction Profile Summary

The official interaction profile is defined by two primary non-systemic restrictions and the lack of established systemic drug interactions. No specific timing-based separation rules for co-administered medicines are required.

Mechanism of Action

Modulating Nerve Cell Electrical Signaling

The primary action of Permethrin involves the direct modulation of voltage-gated sodium channels (VGSCs) on the nerve cell membranes of target arthropods. This binding prevents the channels from closing properly, causing a sustained and excessive influx of sodium ions (Na^+). This molecular event triggers an uncontrollable neuro-electrical hyperstimulation that leads to the subsequent loss of motor control and systemic failure in the target organism.


The Cascade of Neurological Overstimulation

The continuous flow of sodium ions forces the nerve cells into a state of persistent depolarization, leading to repetitive and uncontrolled firing of nerve impulses. This overwhelming neurological activity quickly escalates, moving beyond the cellular level to affect the target organism's entire motor and respiratory systems. The resulting paralysis is the physiological consequence of this specific cascade of biochemical events.


Mechanism Selectivity and Potentiation

Permethrin's mechanism exhibits selective toxicity due to structural differences in the VGSCs of target organisms versus mammals, ensuring the neurotoxic effects are constrained almost exclusively to the target arthropods. Furthermore, in some formulations, the mechanism is enhanced by metabolic inhibitors (like PBO) that block the target organism's detoxification enzymes, thereby resulting in a sustained presence of the molecule at the nerve channel.

Dosage and Administration Information

Pertrin (Permethrin) is administered exclusively via the topical route and is formulated into specific preparations corresponding to the target parasitic infestation. The dosing regimen is fundamentally defined by a single-application course of therapy, which must be followed by a period of observation before any possible re-treatment. The 5% cream formulation is typically used for scabies, while the 1% lotion or rinse is designated for pediculosis.

The use of the 5% cream requires the dose to cover the entire body, generally from the neck down, and must remain on the skin for a mandatory contact duration of 8 to 14 hours before being washed off. If the hands are washed during this window, the cream must be immediately reapplied to ensure full therapeutic coverage. This application must be done on clean, cool skin.

Conversely, the 1% formulation, which is applied to the hair and scalp, mandates a shorter, fixed contact time of 10 minutes before rinsing. The 1% rinse must be applied to hair that has been washed, rinsed, and is just damp, with avoidance of hair conditioner beforehand.

Treatment is considered an intermittent course. If the initial application fails to clear the infestation, a second, single application may be considered. For scabies, this re-treatment is typically permitted 14 days after the first application. For head lice, the minimum interval before a second course is generally 7 to 10 days.

Specific rules for the application area exist for certain age groups. When the 5% cream is used in patients 2 months of age and older, the application must be extended to include the scalp, temple, and forehead, a principle also applied to older adults.

Recent Clinical Evidence

Permethrin is a synthetic neurotoxic pyrethroid agent commonly used in topical formulations for treating parasitic infestations, primarily scabies and pediculosis capitis (head lice). Recent clinical research focuses primarily on its efficacy profile, comparison to alternative treatments, and emerging resistance concerns.

Efficacy and Comparative Studies

Clinical trials, including randomized controlled trials (RCTs), have evaluated the efficacy of topical 5% permethrin cream for scabies:

  • Scabies Treatment: Several studies suggest that 5% permethrin cream and oral ivermectin show similar efficacy rates for scabies after two weeks. However, one network meta-analysis found that combination treatment using both permethrin and oral ivermectin was associated with the highest cure rate.
  • Lice Treatment: For head lice, 1% permethrin lotion/shampoo is often cited as a first-line treatment. Recent trials have compared its effectiveness to newer agents, with some findings suggesting that treatments like dimethicone may be associated with higher cure rates.

Resistance and Tolerability

Resistance: Increasing reports of permethrin treatment failure in scabies have raised concerns about emerging resistance. Genetic mutations in the mite's voltage-gated sodium channel gene, the drug's primary target, have been identified as a key factor contributing to this resistance in certain populations. However, some researchers attribute treatment failure to poor adherence or improper application, classifying it as pseudo-resistance.

Safety: Permethrin is generally associated with limited systemic absorption (less than 2% is absorbed through the skin). The most commonly reported side effects in trials are temporary localized reactions at the application site, such as mild stinging, burning, skin irritation, and temporary itching, often linked to the primary infestation rather than the medication itself.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE) Clinical Guideline: Scabies management

Frequently Asked Questions (FAQ)

Common questions about Pertrin (Permethrin) (FAQ)

Q: Can I drink alcohol while taking this medication?

According to the official product information, there is a strong caution against consuming alcohol in any form while this medication is being used. This restriction extends for a period of up to 14 days after the last dose. The combination of the medication and alcohol has been associated with the potential for a severe reaction.

Q: Does this medicine cause drowsiness or make me sleepy?

Regulatory documents indicate that some individuals may experience a sedative effect, which means feeling drowsy or sleepy. The sedative effect has led to the recommendation that some individuals take the medication at bedtime, as noted in the product information.

Q: Is this medication safe to use during pregnancy?

Official product information states that the use of this medication is contraindicated during pregnancy, meaning its use is not recommended due to the potential for harm to the fetus. Official safety information includes a recommendation for using a non-hormonal method of contraception during therapy.

Q: How should I store this medication?

According to regulatory guidelines, the medication should be stored at controlled room temperature, specifically between 20 C and 25 C (or 68 F and 77 F). This specified temperature range is required to maintain the quality and stability of the product as regulated by official guidance.

How should Pertrin (Permethrin) be stored and disposed of?

How to Store and Dispose of Permethrin Topical Products

Permethrin cream and lotion must be stored at Controlled Room Temperature, typically mathbf20^circC to mathbf25^circC (mathbf68^circF to mathbf77^circF). It is essential to keep the medicine from freezing and store it away from excess heat, moisture, and direct light to maintain stability.

Protection and Safety

The product must be kept in its original container and be tightly closed. A mandatory requirement is to store the medication out of the reach of children and pets, often specified as storing it locked up.

Disposal Guidelines

Unused or expired permethrin should not be disposed of in household trash or via wastewater (sinks or toilets). Disposal must be done according to local, state, and federal regulations to protect the environment, as permethrin is toxic to aquatic life. Consult a pharmacist or local waste disposal program for guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pertrin (Permethrin) found in:

A-Z Index: